Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and is associated with development of metabolic disease including atherosclerotic cardiovascular disease (CVD). Our aim is to examine the association of hepatic steatosis with prevalent clinical and subclinical CVD...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Hepatol
Prif Awduron: Mellinger, Jessica L., Pencina, Karol M., Massaro, Joseph M., Hoffmann, Udo, Seshadri, Sudha, Fox, Caroline S., O'Donnell, Christopher J., Speliotes, Elizabeth K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282653/
https://ncbi.nlm.nih.gov/pubmed/25776891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2015.02.045
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg